FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q28210890> ?p ?o ?g. }

• Q28210890 description "2004 nî lūn-bûn" @default.
• Q28210890 description "2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած" @default.
• Q28210890 description "2004 թվականի օգոստոսին հրատարակված գիտական հոդված" @default.
• Q28210890 description "2004年の論文" @default.
• Q28210890 description "2004年論文" @default.
• Q28210890 description "2004年論文" @default.
• Q28210890 description "2004年論文" @default.
• Q28210890 description "2004年論文" @default.
• Q28210890 description "2004年論文" @default.
• Q28210890 description "2004年论文" @default.
• Q28210890 description "2004年论文" @default.
• Q28210890 description "2004年论文" @default.
• Q28210890 description "2004年论文" @default.
• Q28210890 description "2004年论文" @default.
• Q28210890 description "2004年论文" @default.
• Q28210890 description "2004년 논문" @default.
• Q28210890 description "article científic" @default.
• Q28210890 description "article scientific" @default.
• Q28210890 description "article scientifique" @default.
• Q28210890 description "articol științific" @default.
• Q28210890 description "articolo scientifico" @default.
• Q28210890 description "artigo científico" @default.
• Q28210890 description "artigo científico" @default.
• Q28210890 description "artigo científico" @default.
• Q28210890 description "artikull shkencor" @default.
• Q28210890 description "artikulong pang-agham" @default.
• Q28210890 description "artykuł naukowy" @default.
• Q28210890 description "artículo científico publicado en 2004" @default.
• Q28210890 description "artículu científicu espublizáu en 2004" @default.
• Q28210890 description "bilimsel makale" @default.
• Q28210890 description "bài báo khoa học" @default.
• Q28210890 description "mokslinis straipsnis" @default.
• Q28210890 description "naučni članak" @default.
• Q28210890 description "scienca artikolo" @default.
• Q28210890 description "scientific article (publication date: August 2004)" @default.
• Q28210890 description "teaduslik artikkel" @default.
• Q28210890 description "tieteellinen artikkeli" @default.
• Q28210890 description "tudományos cikk" @default.
• Q28210890 description "vedecký článok (publikovaný 2004-08)" @default.
• Q28210890 description "vetenskaplig artikel" @default.
• Q28210890 description "videnskabelig artikel" @default.
• Q28210890 description "vitenskapelig artikkel" @default.
• Q28210890 description "vitskapeleg artikkel" @default.
• Q28210890 description "vědecký článek publikovaný v roce 2004" @default.
• Q28210890 description "wetenschappelijk artikel (gepubliceerd in 2004-08)" @default.
• Q28210890 description "wissenschaftlicher Artikel" @default.
• Q28210890 description "επιστημονικό άρθρο" @default.
• Q28210890 description "мақолаи илмӣ" @default.
• Q28210890 description "мақолаи илмӣ" @default.
• Q28210890 description "наукова стаття, опублікована в серпні 2004" @default.
• Q28210890 description "научна статия" @default.
• Q28210890 description "научная статья" @default.
• Q28210890 description "научни чланак" @default.
• Q28210890 description "научни чланак" @default.
• Q28210890 description "מאמר מדעי" @default.
• Q28210890 description "مقالة علمية (نشرت في أغسطس 2004)" @default.
• Q28210890 description "২০০৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q28210890 description "บทความทางวิทยาศาสตร์" @default.
• Q28210890 description "სამეცნიერო სტატია" @default.
• Q28210890 name "Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial" @default.
• Q28210890 name "Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial" @default.
• Q28210890 name "Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial" @default.
• Q28210890 type Item @default.
• Q28210890 label "Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial" @default.
• Q28210890 label "Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial" @default.
• Q28210890 label "Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial" @default.
• Q28210890 prefLabel "Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial" @default.
• Q28210890 prefLabel "Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial" @default.
• Q28210890 prefLabel "Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial" @default.
• Q28210890 P1433 Q28210890-CB4F81B8-72A0-4299-ACA2-CB892D2BB452 @default.
• Q28210890 P1476 Q28210890-596C55DC-C6F2-4C61-A0F0-0FD2C05B29F3 @default.
• Q28210890 P304 Q28210890-78492240-CD41-40BD-AEFF-496185F24D47 @default.
• Q28210890 P31 Q28210890-28039DAF-AFC5-4F57-A082-4050C690088F @default.
• Q28210890 P356 Q28210890-284CAD1F-7E9D-4312-8856-2EDDAFA17E53 @default.
• Q28210890 P407 Q28210890-97DE851D-DABF-40FD-B8B1-74E4EF42CF18 @default.
• Q28210890 P433 Q28210890-5DDF3DFA-A5E7-46E9-9140-B7A6A4FA4A61 @default.
• Q28210890 P478 Q28210890-CA92303B-FA1F-421E-9E52-63E38BC5BF38 @default.
• Q28210890 P50 Q28210890-D5BD620C-EA07-419F-821B-1E50C1E4BD89 @default.
• Q28210890 P50 Q28210890-FDE60E29-3E68-4BE1-97F2-490825B1EA2D @default.
• Q28210890 P577 Q28210890-3D5716E1-017B-4804-8A46-83754A039C12 @default.
• Q28210890 P698 Q28210890-1C2306AB-135A-4A59-8D1D-28201CFE43E3 @default.
• Q28210890 P921 Q28210890-3F83C612-EFC9-45A3-BDBA-4C79A221B9D6 @default.
• Q28210890 P921 Q28210890-EE73371D-2893-438D-877C-239FE84EE545 @default.
• Q28210890 P356 J.AHJ.2004.03.028 @default.
• Q28210890 P698 15308995 @default.
• Q28210890 P1433 Q2227156 @default.
• Q28210890 P1476 "Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial" @default.
• Q28210890 P304 "263-8" @default.
• Q28210890 P31 Q13442814 @default.
• Q28210890 P356 "10.1016/J.AHJ.2004.03.028" @default.
• Q28210890 P407 Q1860 @default.
• Q28210890 P433 "2" @default.
• Q28210890 P478 "148" @default.
• Q28210890 P50 Q47264894 @default.
• Q28210890 P50 Q5387640 @default.
• Q28210890 P577 "2004-08-01T00:00:00Z" @default.
• Q28210890 P698 "15308995" @default.
• Q28210890 P921 Q18216 @default.
• Q28210890 P921 Q410237 @default.